Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

archimed.co.uk

Stage

Acquired | Acquired

About Archimed

Archimed has developed two easy-to-use wound dressings that can help accelerate wound healing. The company's products, Oxyzyme and Iodozyme, were developed in the UK by a scientific team with a long history of medical innovation. Professor Paul Davis, Archimed's CTO, patented the technology which enabled the development of the highly successful Clear-Blue pregnancy test.

Archimed Headquarters Location

King Edward Court, King Edward Road Knutsford

Cheshire, England, WA16 0BE,

United Kingdom

+44 (0) 1565 654920

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Archimed Patents

Archimed has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/4/2004

4/19/2011

Traumatology, Medical treatments, Epidermal nevi, neoplasms, cysts, Injuries, Medical equipment

Grant

Application Date

6/4/2004

Grant Date

4/19/2011

Title

Related Topics

Traumatology, Medical treatments, Epidermal nevi, neoplasms, cysts, Injuries, Medical equipment

Status

Grant

Latest Archimed News

Italy: UPS to acquire Bomi from ArchiMed

Aug 9, 2022

The healthcare arm of US-based UPS, the world’s largest courier and logistics group, has reached an agreement to acquire healthcare logistics provider Bomi Group from private equity healthcare specialist, ArchiMed. Bomi Group, headquartered in Spino d’Adda, Italy, and founded in 1985, provides services for the medtech and pharma sectors. The acquisition will add more than […]

  • Where is Archimed's headquarters?

    Archimed's headquarters is located at King Edward Court, King Edward Road, Cheshire.

  • What is Archimed's latest funding round?

    Archimed's latest funding round is Acquired.

  • Who are the investors of Archimed?

    Investors of Archimed include Crawford Healthcare and Unilever Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.